Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Riociguat in the Treatment of Pulmonary Arterial Hypertension.
Jerjes-Sánchez C, Glenn-Valdez H, Zayas N, Cueto-Robledo G, Bonola L, Pech-Alonso B, Ramírez A, Flores-Puente F, García-Aguilar H, Espitia-Hernández G, Montes GP, Pulido T. Jerjes-Sánchez C, et al. Among authors: pulido t. Arch Med Res. 2022 Jun;53(4):352-358. doi: 10.1016/j.arcmed.2022.04.001. Epub 2022 Apr 27. Arch Med Res. 2022. PMID: 35487793 Review.
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America.
Orozco-Levi M, Cáneva J, Fernandes C, Restrepo-Jaramillo R, Zayas N, Conde R, Diez M, Jardim C, Pacheco Gallego MC, Melatini L, Valdéz H, Pulido T. Orozco-Levi M, et al. Among authors: pulido t. Pulm Circ. 2022 Jan 12;12(1):e12012. doi: 10.1002/pul2.12012. eCollection 2022 Jan. Pulm Circ. 2022. PMID: 35506085 Free PMC article.
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial.
White RJ, Jerjes-Sanchez C, Bohns Meyer GM, Pulido T, Sepulveda P, Wang KY, Grünig E, Hiremath S, Yu Z, Gangcheng Z, Yip WLJ, Zhang S, Khan A, Deng CQ, Grover R, Tapson VF; FREEDOM-EV Investigators. White RJ, et al. Among authors: pulido t. Am J Respir Crit Care Med. 2020 Mar 15;201(6):707-717. doi: 10.1164/rccm.201908-1640OC. Am J Respir Crit Care Med. 2020. PMID: 31765604 Free PMC article. Clinical Trial.
Management of pulmonary hypertension in special conditions.
Preston IR, Howard LS, Langleben D, Lichtblau M, Pulido T, Souza R, Olsson KM. Preston IR, et al. Among authors: pulido t. Eur Respir J. 2024 Oct 31;64(4):2401180. doi: 10.1183/13993003.01180-2024. Print 2024 Oct. Eur Respir J. 2024. PMID: 39209477 Free PMC article. Review.
Macitentan in the treatment of pulmonary arterial hypertension.
Zebadúa R, Hernández-Pérez AP, García A, Zayas N, Sandoval J, López J, Pulido T. Zebadúa R, et al. Among authors: pulido t. Future Cardiol. 2021 Jan;17(1):49-58. doi: 10.2217/fca-2020-0012. Epub 2020 Jul 17. Future Cardiol. 2021. PMID: 32677463 Review.
Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension.
Souza R, Delcroix M, Galié N, Jansa P, Mehta S, Pulido T, Rubin L, Sastry BKS, Simonneau G, Sitbon O, Torbicki A, Boyanova N, Chamitava L, Stein C, Channick RN. Souza R, et al. Among authors: pulido t. Adv Ther. 2022 Sep;39(9):4374-4390. doi: 10.1007/s12325-022-02199-x. Epub 2022 Jul 12. Adv Ther. 2022. PMID: 35819570 Free PMC article. Clinical Trial.
81 results